J&J s COVID-19 vaccine could protect millions - if people take it
One-dose version s overall efficacy is below Pfizer, Moderna
Angelica LaVito and Riley Griffin, Bloomberg
March 1, 2021
FacebookTwitterEmail
Johnson & Johnson’s Covid-19 vaccine could protect millions more Americans from contracting the coronavirus. The key will be assuring people that the single-shot vaccine is worth taking, as its overall efficacy appears lower than the two-dose ones already on the market in the U.S.
J&J’s shot, which U.S. regulators authorized Saturday, is more convenient than the vaccines cleared by the Food and Drug Administration last year. It requires one injection and can be stored for months in a refrigerator. State health officials and the Biden administration see it as a way to quickly host mass clinics as more transmissible virus variants continue to spread. Yet the ease of distributing the vaccine will need to be balanced with the risk of creating the perception that J&J’s sho
Israel gives half of population at least one COVID shot
Yaacov Benmeleh, Bloomberg
FacebookTwitterEmail
Israel has now vaccinated half its population against Covid-19, another milestone on the way to subduing the pandemic.
More than 4.6 million people have gotten at least one dose of the vaccine from Pfizer Inc. and BioNTech SE, according to Health Ministry data released Friday. With nearly 8% of the country having recovered from the disease and likely developing some resistance to reinfection, that could bring Israel closer to herd immunity.
Vaccinating about 60% to 70% of the population should be enough to rein in infections, illness and death, estimates Raina MacIntyre, a professor of biosecurity at the University of New South Wales, based off the latest data from Israel.
Pfizer, BioNTech shot may defeat new variants, study shows lmtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lmtonline.com Daily Mail and Mail on Sunday newspapers.